All In Biotech

Drug Trial Radar · NCT05192369

A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers

A Four-Arm, Randomized, Crossover, Placebo and Active Controlled Study for the Evaluation of the Effect of Therapeutic and Supratherapeutic Doses of CTP-543 on the QT/QTc Intervals in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Mar 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Jan 4, 2022

Primary completion

Jan 28, 2022

Study completion Jan 28, 2022

Sponsor

Lead sponsor
Concert PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jan 14, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a four-arm, randomized, crossover, placebo and active controlled study to evaluate of the effect of therapeutic and supratherapeutic doses of CTP-543 on the QT/QTc intervals in healthy volunteers

Conditions

  • Healthy Volunteers

Interventions

  • CTP-543Drug

    CTP-543 12 mg (1 x 12 mg tablet), dosed with water

  • CTP-543Drug

    CTP-543 48 mg (4 x 12 mg tablet) dosed with water

  • MoxifloxacinDrug

    Moxifloxacin (1 x 400 mg tablet) dosed with water

  • PlaceboDrug

    Placebo (1 tablet) dosed with water

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TQT AnalysisTime frame: Before dosing (pre-dose) through 24 hours post-dose on Day 1, Day 4, Day 7, and Day 10

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinical Pharmacology of Miami, LLC

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.